Treace James T. - 15 Aug 2024 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Reporting relationship: Director
Issuer ticker: TMCI
Reported as of: 15 Aug 2024
Net transaction value: +$501,035
SEC form: 4
Accepted by SEC: 19 Aug 2024, 09:00:08 UTC
Prior SEC filing: 03 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Lisa Taylor as Attorney-in-fact for James Treace

Key filing fact

Treace James T. filed Form 4 for TREACE MEDICAL CONCEPTS, INC. (TMCI) on 19 Aug 2024.

Key facts

This page summarizes Treace James T.'s Form 4 filing for TREACE MEDICAL CONCEPTS, INC. (TMCI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 Aug 2024, 09:00.

Change

Previous filing in this sequence was filed on 03 Jun 2024.
Current net transaction value: +$501,035.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TMCI transaction

Common Stock

Purchase

Transaction value: $501,035
Shares: +84,000
Change %: +7.4%
Price: $5.96
Shares after: 1,223,441
Date: 15 Aug 2024
Ownership: Direct
Footnotes: F1

TMCI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 556,183
Date: 15 Aug 2024
Ownership: By spouse

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.9100 to $6.0450 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.